SCHEMBL30983045

SCHEMBL30983045

CCCCCCCCCCCCCCCCn1ccc(=O)c(O)c1C#N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
KDM4E B2RXH2 5/20 0.39
HTT P42858 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
MAPT P10636 2/20 0.39
LMNA P02545 1/20 0.39
GRM2 Q14416 2/20 0.37
TYR P14679 1/20 0.36
PTGS1 P23219 3/20 0.36
PTGS2 P35354 3/20 0.36
MGLL Q99685 2/20 0.36
CYP2C19 P33261 2/20 0.36
KDM6A O15550 1/20 0.36
KDM4A O75164 1/20 0.36
CYP2C9 P11712 1/20 0.36
KDM5C P41229 1/20 0.36
KDM2B Q8NHM5 1/20 0.36
DOHH Q9BU89 1/20 0.36
KDM2A Q9Y2K7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30982527 1.00 APP (0.40) APPHRH3KDM4EHTTSMN1; SMN2
SCHEMBL30982601 1.00 APP (0.40) APPHRH3KDM4EHTTSMN1; SMN2
SCHEMBL30982688 0.82 KDM4E (0.44) APPHRH3KDM4EHTTSMN1; SMN2
SCHEMBL30982556 0.82 KDM4E (0.44) APPHRH3KDM4EHTTSMN1; SMN2
SCHEMBL30982792 0.82 KDM4E (0.44) APPHRH3KDM4EHTTSMN1; SMN2
SCHEMBL30982765 0.81 KDM4E (0.39) KDM4EHTTSMN1; SMN2MAPTLMNA
SCHEMBL30982638 0.81 KDM4E (0.39) KDM4EHTTSMN1; SMN2MAPTLMNA
SCHEMBL30982784 0.81 KDM4E (0.39) KDM4EHTTSMN1; SMN2MAPTLMNA
SCHEMBL10926016 0.79 APP (0.56) APPHRH3KDM4EHTTSMN1; SMN2
SCHEMBL5179451 0.79 APP (0.56) APPHRH3KDM4EHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12606766-B2 Multipurpose oxypyridinones and their functional use-4 INFINEUM INTERNATIONAL LIMITED (US) 2026-04-21 US disclosed
US-12606765-B2 Multipurpose oxypyridinones and their functional use—1 INFINEUM INTERNATIONAL LIMITED (US) 2026-04-21 US disclosed
US-12503666-B2 Multipurpose oxypyridinones and their functional use-2 INFINEUM INTERNATIONAL LIMITED (US) 2025-12-23 US disclosed
US-20240294842-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-4 INFINEUM INTERNATIONAL LIMITED (US) 2024-09-05 US disclosed
US-20240294840-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-2 INFINEUM INTERNATIONAL LIMITED (US) 2024-09-05 US disclosed
US-20240294841-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-3 INFINEUM INTERNATIONAL LIMITED (US) 2024-09-05 US disclosed
US-20240287405-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE - 1 INFINEUM INTERNATIONAL LIMITED (US) 2024-08-29 US disclosed
EP-4417673-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE Infineum International Limited (GB) 2024-08-21 EP disclosed
EP-4417672-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE Infineum International Limited (GB) 2024-08-21 EP disclosed
EP-4417674-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE Infineum International Limited (GB) 2024-08-21 EP disclosed
EP-4417675-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE Infineum International Limited (GB) 2024-08-21 EP disclosed
CN-118516151-A Multipurpose oxypyridones and their functional use 英菲诺姆国际有限公司 2024-08-20 CN disclosed
CN-118516152-A Multipurpose oxypyridones and their functional use 英菲诺姆国际有限公司 2024-08-20 CN disclosed
CN-118516154-A Multipurpose oxypyridones and their functional use 英菲诺姆国际有限公司 2024-08-20 CN disclosed
CN-118516153-A Multipurpose oxypyridones and their functional use 英菲诺姆国际有限公司 2024-08-20 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240294840-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-2 SIGMAR1, OXGR1, OPRM1 APP 4262/4885HRH3 906/4885KDM4E 2896/4885
US-12606766-B2 Multipurpose oxypyridinones and their functional use-4 PHOSPHO1, SIGMAR1, SGMS1 APP 4450/4885HRH3 2496/4885KDM4E 2276/4885
US-12606765-B2 Multipurpose oxypyridinones and their functional use—1 SIGMAR1, PHOSPHO1, SGMS1 APP 4519/4885HRH3 3678/4885KDM4E 3439/4885
US-12503666-B2 Multipurpose oxypyridinones and their functional use-2 SIGMAR1, OXGR1, OPRM1 APP 4262/4885HRH3 906/4885KDM4E 2896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.